- Instruments
- Consumables and Reagents
- Software and Services
Cell Analysis Market size was valued at USD 17,500.0 Mn in 2022 and is poised to grow at a CAGR of 10.4 % over 2023-2029. Cell analysis is to evaluate the fundamental state of the cell, such as the cell's metabolic parameters, cell health, viability, cellular activation, cell-mediated toxicity, cell death, and other parameters, which is helpful in basic research to study disease progression, drug discovery, development, and its clinical application. According to the Centre for Disease Control and Prevention 2020, during COVID-19, RT-PCR was 72.1% more sensitive and 98.7% more specific when compared to the Antigen test. Moreover, according to a research study in 2023, the clinical application of Flow cytometry is increasing for the identification of leukemia and lymphomas and to enumerate tumorigenic abnormality in cancer patients. The cell analysis market is flourishing in recent decades due to the increase in the prevalence of viral diseases and has led to increased demand for diagnostic tests like ELISA, PCR, and Electron microscopy. Cell-based assays are the recent trend in drug discovery since they are more accurate when compared to other assays. Strong R&D activities for the development of personalized medicine, advancements in stem cell research, and growing awareness of cell-based therapies are driving the cell analysis market. Moreover, a greater understanding of the diagnosis increases in cancer and its types, an increase in the incidence of infectious diseases, and the recent waves of the pandemic have heightened the cell analysis market in upcoming years. Advances in technology have led to the development of automated cell analysis that delivers accurate and reliable results promptly and reduces the costs associated with manual measurements, and can be used to monitor patients in real-time.
Cell Analysis Market Key Developments:
Study Period
Base Year
CAGR
Largest Market
Fastest Growing Market
Biomarker testing is one of the best ways for early cancer diagnosis and contributes tremendously to the cell analysis market. Cancer biomarkers are genes, proteins, or other substances that can be tested to reveal important information about a person's cancer. Each person has a unique pattern of biomarkers and it affects how certain treatments will work. Samples from suspected areas are collected and tests are conducted to find the difference between genes in cancer cells and healthy cells. Testing two types of cells can show whether the change in cancer cells is somatic or genetic. Biomarkers in the cancer cells are detected and accordingly, a treatment plan that can help the patient is selected. Apart from treatment, it is also used in determining the early stage of cancer. According to a research study, the use of biomarker testing showed a tremendous increase from 33% in 2016 to 81% in 2018.
The global cell analysis market was valued at USD 17,500.0 million in 2022 and is expected to grow at 10.4% CAGR over the forecast period 2023 – 2029.
The increasing number of products by different companies leads to fierce competition, and accuracy in test results in the cell analysis market.
The increase in the adoption of advanced technologies such as PCR and cell imaging for their accuracy is a major trend in the cell analysis market.
Currently North America is leading the cell analysis market due to its advanced technology; however, the Asia Pacific cell analysis market might lead in the upcoming future due to its increasing population.
Thermo Fisher Scientific (US), Agilent Technologies (US), Sigma-Aldrich (US), Sartorius (Germany), Enzo Life Sciences (US), and Dickinson and Company (US) are a few companies operating in the cell analysis market.
1.Executive Summary |
2.Global Cell Analysis Market Introduction |
2.1.Global Cell Analysis Market - Taxonomy |
2.2.Global Cell Analysis Market - Definitions |
2.2.1.Product Type |
2.2.2.Application |
2.2.3.Techniques |
2.2.4.End User |
2.2.5.Region |
3.Global Cell Analysis Market Dynamics |
3.1. Drivers |
3.2. Restraints |
3.3. Opportunities/Unmet Needs of the Market |
3.4. Trends |
3.5. Product Landscape |
3.6. New Product Launches |
3.7. Impact of COVID 19 on Market |
4.Global Cell Analysis Market Analysis, 2018-2022 and Forecast 2023-2029 |
4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
4.3. Market Opportunity Analysis |
5.Global Cell Analysis Market By Product Type, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
5.1. Instruments |
5.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.3. Market Opportunity Analysis |
5.2. Consumables and Reagents |
5.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.2.3. Market Opportunity Analysis |
5.3. Software and Services |
5.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.3.3. Market Opportunity Analysis |
6.Global Cell Analysis Market By Application, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
6.1. Disease diagnosis |
6.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.1.3. Market Opportunity Analysis |
6.2. Biomarker Discovery |
6.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.2.3. Market Opportunity Analysis |
6.3. Drug discovery |
6.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.3.3. Market Opportunity Analysis |
6.4. Personalized Medicine |
6.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.4.3. Market Opportunity Analysis |
6.5. Others |
6.5.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
6.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.5.3. Market Opportunity Analysis |
7.Global Cell Analysis Market By Techniques, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
7.1. Flow Cytometry |
7.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.1.3. Market Opportunity Analysis |
7.2. Spectrophotometry |
7.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.2.3. Market Opportunity Analysis |
7.3. PCR |
7.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.3.3. Market Opportunity Analysis |
7.4. Next Generation Sequencing |
7.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.4.3. Market Opportunity Analysis |
7.5. Microscope |
7.5.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
7.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.5.3. Market Opportunity Analysis |
7.6. Microarray |
7.6.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
7.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.6.3. Market Opportunity Analysis |
7.7. Blotting techniques |
7.7.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
7.7.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.7.3. Market Opportunity Analysis |
7.8. Others |
7.8.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
7.8.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.8.3. Market Opportunity Analysis |
8.Global Cell Analysis Market By End User, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
8.1. Hospitals and Clinics |
8.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.1.3. Market Opportunity Analysis |
8.2. Pharmaceutical and Biotechnology Companies |
8.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.2.3. Market Opportunity Analysis |
8.3. Academic and Research Institutes |
8.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.3.3. Market Opportunity Analysis |
8.4. Diagnostic Centres |
8.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.4.3. Market Opportunity Analysis |
9.Global Cell Analysis Market By Region, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
9.1. North America |
9.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
9.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.1.3. Market Opportunity Analysis |
9.2. Europe |
9.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
9.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.2.3. Market Opportunity Analysis |
9.3. Asia Pacific (APAC) |
9.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
9.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.3.3. Market Opportunity Analysis |
9.4. Middle East and Africa (MEA) |
9.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
9.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.4.3. Market Opportunity Analysis |
9.5. Latin America |
9.5.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
9.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.5.3. Market Opportunity Analysis |
10.North America Cell Analysis Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
10.1. Product Type Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.1.1.Instruments |
10.1.2.Consumables and Reagents |
10.1.3.Software and Services |
10.2. Application Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.2.1.Disease diagnosis |
10.2.2.Biomarker Discovery |
10.2.3.Drug discovery |
10.2.4.Personalized Medicine |
10.2.5.Others |
10.3. Techniques Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.3.1.Flow Cytometry |
10.3.2.Spectrophotometry |
10.3.3.PCR |
10.3.4.Next Generation Sequencing |
10.3.5.Microscope |
10.3.6.Microarray |
10.3.7.Blotting techniques |
10.3.8.Others |
10.4. End User Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.4.1.Hospitals and Clinics |
10.4.2.Pharmaceutical and Biotechnology Companies |
10.4.3.Academic and Research Institutes |
10.4.4.Diagnostic Centres |
10.5. Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.5.1.United States of America (USA) |
10.5.2.Canada |
11.Europe Cell Analysis Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
11.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.1.1.Instruments |
11.1.2.Consumables and Reagents |
11.1.3.Software and Services |
11.2. Application Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.2.1.Disease diagnosis |
11.2.2.Biomarker Discovery |
11.2.3.Drug discovery |
11.2.4.Personalized Medicine |
11.2.5.Others |
11.3. Techniques Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.3.1.Flow Cytometry |
11.3.2.Spectrophotometry |
11.3.3.PCR |
11.3.4.Next Generation Sequencing |
11.3.5.Microscope |
11.3.6.Microarray |
11.3.7.Blotting techniques |
11.3.8.Others |
11.4. End User Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.4.1.Hospitals and Clinics |
11.4.2.Pharmaceutical and Biotechnology Companies |
11.4.3.Academic and Research Institutes |
11.4.4.Diagnostic Centres |
11.5. Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.5.1.Germany |
11.5.2.France |
11.5.3.Italy |
11.5.4.United Kingdom (UK) |
11.5.5.Spain |
11.5.6.Rest of EU |
12.Asia Pacific (APAC) Cell Analysis Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
12.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.1.1.Instruments |
12.1.2.Consumables and Reagents |
12.1.3.Software and Services |
12.2. Application Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.2.1.Disease diagnosis |
12.2.2.Biomarker Discovery |
12.2.3.Drug discovery |
12.2.4.Personalized Medicine |
12.2.5.Others |
12.3. Techniques Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.3.1.Flow Cytometry |
12.3.2.Spectrophotometry |
12.3.3.PCR |
12.3.4.Next Generation Sequencing |
12.3.5.Microscope |
12.3.6.Microarray |
12.3.7.Blotting techniques |
12.3.8.Others |
12.4. End User Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.4.1.Hospitals and Clinics |
12.4.2.Pharmaceutical and Biotechnology Companies |
12.4.3.Academic and Research Institutes |
12.4.4.Diagnostic Centres |
12.5. Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.5.1.China |
12.5.2.India |
12.5.3.Australia and New Zealand (ANZ) |
12.5.4.Japan |
12.5.5.Rest of APAC |
13.Middle East and Africa (MEA) Cell Analysis Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
13.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.1.1.Instruments |
13.1.2.Consumables and Reagents |
13.1.3.Software and Services |
13.2. Application Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.2.1.Disease diagnosis |
13.2.2.Biomarker Discovery |
13.2.3.Drug discovery |
13.2.4.Personalized Medicine |
13.2.5.Others |
13.3. Techniques Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.3.1.Flow Cytometry |
13.3.2.Spectrophotometry |
13.3.3.PCR |
13.3.4.Next Generation Sequencing |
13.3.5.Microscope |
13.3.6.Microarray |
13.3.7.Blotting techniques |
13.3.8.Others |
13.4. End User Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.4.1.Hospitals and Clinics |
13.4.2.Pharmaceutical and Biotechnology Companies |
13.4.3.Academic and Research Institutes |
13.4.4.Diagnostic Centres |
13.5. Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.5.1.GCC Countries |
13.5.2.South Africa |
13.5.3.Rest of MEA |
14.Latin America Cell Analysis Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
14.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
14.1.1.Instruments |
14.1.2.Consumables and Reagents |
14.1.3.Software and Services |
14.2. Application Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
14.2.1.Disease diagnosis |
14.2.2.Biomarker Discovery |
14.2.3.Drug discovery |
14.2.4.Personalized Medicine |
14.2.5.Others |
14.3. Techniques Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
14.3.1.Flow Cytometry |
14.3.2.Spectrophotometry |
14.3.3.PCR |
14.3.4.Next Generation Sequencing |
14.3.5.Microscope |
14.3.6.Microarray |
14.3.7.Blotting techniques |
14.3.8.Others |
14.4. End User Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
14.4.1.Hospitals and Clinics |
14.4.2.Pharmaceutical and Biotechnology Companies |
14.4.3.Academic and Research Institutes |
14.4.4.Diagnostic Centres |
14.5. Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
14.5.1.Brazil |
14.5.2.Mexico |
14.5.3.Rest of LA |
15. Competition Landscape |
15.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
15.2.1.Thermo Fisher Scientific (US) |
15.2.2.Biocompare (US) |
15.2.3.Agilent Technologies (US) |
15.2.4.Sigma-Aldrich (US) |
15.2.5.Sartorius (Germany) |
15.2.6.Enzo Life Sciences (US) |
15.2.7.Dickinson and Company (US) |
15.2.8.Danaher Corporation (US) |
15.2.9.Bio-Rad Laboratories (US) |
15.2.10.Promega Corporation (US) |
15.2.11.Illumina (US) |
15.2.12.Merck (US) |
15.2.13.Olympus Life Science (Japan) |
15.2.14.QIAGEN (US) |
15.2.15.CELLINK (US) |
15.2.16.PerkinElmer Inc. (US) |
16. Research Methodology |
17. Appendix and Abbreviations |